D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 91 Citations 35,198 259 World Ranking 622 National Ranking 360
Medicine D-index 119 Citations 57,364 603 World Ranking 2172 National Ranking 1257

Research.com Recognitions

Awards & Achievements

1997 - Fellow of the American Academy of Arts and Sciences

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Disease

Stephen L. Hauser mostly deals with Multiple sclerosis, Immunology, Genetics, Allele and Internal medicine. His work carried out in the field of Multiple sclerosis brings together such families of science as Central nervous system disease, Surgery, Disease, Pathology and Myelin. His Disease research includes themes of Pathogenesis, Immune system, Natural history, Neuroscience and Pediatrics.

His Immunology study frequently draws connections between related disciplines such as Myelin basic protein. His Allele research focuses on subjects like Locus, which are linked to Genetic admixture and Age of onset. The concepts of his Internal medicine study are interwoven with issues in Placebo and Ocrelizumab.

His most cited work include:

  • Harrison's Principles of Internal Medicine (12175 citations)
  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (1970 citations)
  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. (1745 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Multiple sclerosis, Immunology, Genetics, Internal medicine and Ocrelizumab. His biological study deals with issues like Genetic association, which deal with fields such as Genome-wide association study. His work in Immune system, T cell, Antigen, Antibody and Encephalomyelitis are all subfields of Immunology research.

His biological study spans a wide range of topics, including Gastroenterology, Endocrinology, Surgery and Oncology. His work deals with themes such as Disability progression, Opera and Placebo, which intersect with Ocrelizumab. His Allele research integrates issues from Human leukocyte antigen, Major histocompatibility complex and Genotype.

He most often published in these fields:

  • Multiple sclerosis (51.18%)
  • Immunology (25.59%)
  • Genetics (20.20%)

What were the highlights of his more recent work (between 2017-2021)?

  • Multiple sclerosis (51.18%)
  • Internal medicine (18.35%)
  • Ocrelizumab (11.11%)

In recent papers he was focusing on the following fields of study:

Stephen L. Hauser mainly investigates Multiple sclerosis, Internal medicine, Ocrelizumab, In patient and Neutrino. His Multiple sclerosis research is classified as research in Immunology. He frequently studies issues relating to Central nervous system and Immunology.

His Internal medicine study combines topics in areas such as Gastroenterology, Oncology and Cardiology. His work in Ocrelizumab tackles topics such as Disability progression which are related to areas like Relapse rate. His Neutrino research includes elements of Universe, Astronomy and Astrophysics.

Between 2017 and 2021, his most popular works were:

  • B-cell Therapy for Multiple Sclerosis: Entering an era. (92 citations)
  • Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. (83 citations)
  • Silent progression in disease activity-free relapsing multiple sclerosis. (81 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Disease

Multiple sclerosis, Internal medicine, Ocrelizumab, Expanded Disability Status Scale and Immunology are his primary areas of study. His Multiple sclerosis study integrates concerns from other disciplines, such as Cohort study, B cell, Disability progression, Magnetic resonance imaging and Disease. His work on Early disease as part of general Disease study is frequently linked to Effective management, therefore connecting diverse disciplines of science.

Stephen L. Hauser has included themes like Genome-wide association study and Oncology in his Internal medicine study. His Ocrelizumab study combines topics from a wide range of disciplines, such as Gastroenterology, Placebo, Randomized controlled trial and Interferon beta-1a. The Immunology study combines topics in areas such as Central nervous system, Allele and Risk factor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Harrison's Principles of Internal Medicine

edotir's Eugene Braunwald....
(1950)

12211 Citations

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Nature (2011)

2667 Citations

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer.
The New England Journal of Medicine (2008)

2450 Citations

Risk alleles for multiple sclerosis identified by a genomewide study.

David A. Hafler;Alastair Compston;Stephen Sawcer;Mark J. Daly.
The New England Journal of Medicine (2007)

2420 Citations

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold.
The New England Journal of Medicine (2017)

1371 Citations

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni.
The New England Journal of Medicine (2017)

1263 Citations

Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

Walter J. Curran;Rebecca Paulus;Corey J. Langer;Ritsuko Komaki.
Journal of the National Cancer Institute (2011)

1235 Citations

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)

1112 Citations

Identification of autoantibodies associated with myelin damage in multiple sclerosis

Claude P. Genain;Barbara Cannella;Stephen L. Hauser;Cedric S. Raine.
Nature Medicine (1999)

1054 Citations

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Hauser Sl;Dawson Dm;Lehrich;Beal Mf.
The New England Journal of Medicine (1983)

971 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stephen L. Hauser

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 164

David A. Hafler

David A. Hafler

Yale University

Publications: 150

Howard L. Weiner

Howard L. Weiner

Harvard University

Publications: 148

Jan Hillert

Jan Hillert

Karolinska Institute

Publications: 127

Gavin Giovannoni

Gavin Giovannoni

Queen Mary University of London

Publications: 123

George C. Ebers

George C. Ebers

University of Oxford

Publications: 121

Hans Lassmann

Hans Lassmann

Medical University of Vienna

Publications: 120

Philip L. De Jager

Philip L. De Jager

Columbia University

Publications: 119

Tomas Olsson

Tomas Olsson

Karolinska Institute

Publications: 117

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 115

Sreeram V. Ramagopalan

Sreeram V. Ramagopalan

University of Oxford

Publications: 115

Roland Martin

Roland Martin

University of Zurich

Publications: 108

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Publications: 106

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 106

Ludwig Kappos

Ludwig Kappos

University Hospital of Basel

Publications: 103

David Reich

David Reich

Harvard Medical School

Publications: 102

Trending Scientists

James K. Gimzewski

James K. Gimzewski

University of California, Los Angeles

Andrew Fire

Andrew Fire

Stanford University

Zubair M. Ahmed

Zubair M. Ahmed

University of Maryland, Baltimore

Kaj Sand-Jensen

Kaj Sand-Jensen

University of Copenhagen

Harald Brüssow

Harald Brüssow

Nestlé (Switzerland)

Henry R. Shinefield

Henry R. Shinefield

University of California, San Francisco

John England

John England

University of Alberta

Dale B. Haidvogel

Dale B. Haidvogel

Rutgers, The State University of New Jersey

Adam R. Clarke

Adam R. Clarke

University of Wollongong

Ronald T. Brown

Ronald T. Brown

University of Nevada, Las Vegas

Heriberto Rodriguez-Martinez

Heriberto Rodriguez-Martinez

Linköping University

David Robertson

David Robertson

Vanderbilt University

Scott A. Rodeo

Scott A. Rodeo

Hospital for Special Surgery

Michael Goggins

Michael Goggins

Johns Hopkins University

Eric Schickler

Eric Schickler

University of California, Berkeley

Igor Soszyński

Igor Soszyński

University of Warsaw

Something went wrong. Please try again later.